Actavis Inc. rejected a cash-and- stock offer from fellow generic drugmaker Mylan Inc. for $15 billion, deciding instead to pursue talks to take over Warner Chilcott Plc, said people familiar with the matter.
AstraZeneca Plc and Cubist Pharmaceuticals Inc. are among the suitors that made first-round bids for Optimer Pharmaceuticals Inc., the antibiotics maker weighing a sale, said people familiar with the matter.
ICU Medical Inc., the San Clemente, California-based producer of intravenous medical equipment, is weighing a sale that may fetch more than $1 billion, said people familiar with the matter. The shares rose to their highest closing price since first being sold to the public 21 years ago.
TPG Capital and Warburg Pincus LLC are exploring a sale or public offering of Neiman Marcus Group Inc. eight years after acquiring the luxury retailer, according to two people familiar with the matter.